Arcellx (ACLX) Non-cash Items (2021 - 2025)

Arcellx's quarterly Non-cash Items came in at $5.8 million in Q4 2025, down 98.61% year-on-year from $415.6 million in Q4 2024, and down 98.61% quarter-over-quarter from $415.6 million in Q4 2024.

Arcellx has reported Non-cash Items for 5 years, with the latest figure at $5.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items fell 98.61% year-over-year to $5.8 million; the trailing twelve-month figure through Dec 2025 stood at $5.8 million (down 98.61% YoY), and the FY2025 full-year result was $5.8 million, up 22.82% from the prior year.
  • Non-cash Items for Q4 2025 stood at $5.8 million, down from $415.6 million in the prior quarter.
  • The five-year high for Non-cash Items was $415.6 million in Q4 2024, with the low at $1.8 million in Q1 2022.
  • Average Non-cash Items over 5 years is $116.9 million, with a median of $7.3 million recorded in 2021.
  • Year-over-year, Non-cash Items soared 9532.19% in 2023 and tumbled 98.61% in 2025.
  • Tracing ACLX's Non-cash Items over 5 years: stood at $7.3 million in 2021, then jumped by 2244.46% to $172.3 million in 2022, then soared by 95.12% to $336.2 million in 2023, then rose by 23.64% to $415.6 million in 2024, then plunged by 98.61% to $5.8 million in 2025.
  • The last three Non-cash Items figures came in at $5.8 million (Q4 2025), $415.6 million (Q4 2024), and $336.2 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Arcellx 6.48 Bn 6.48 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 5.79 Mn
Dec 31, 2025 5.79 Mn
Dec 31, 2024 415.63 Mn
Dec 31, 2024 415.63 Mn
Dec 31, 2023 336.17 Mn
Dec 31, 2023 336.17 Mn
Sep 30, 2023 4.11 Mn
Sep 30, 2023 4.11 Mn
Jun 30, 2023 167.17 Mn
Jun 30, 2023 167.17 Mn
Mar 31, 2023 170.23 Mn
Mar 31, 2023 170.23 Mn
Dec 31, 2022 172.29 Mn
Dec 31, 2022 172.29 Mn
Sep 30, 2022 2.88 Mn
Sep 30, 2022 2.88 Mn
Jun 30, 2022 2.41 Mn
Jun 30, 2022 2.41 Mn
Mar 31, 2022 1.77 Mn
Mar 31, 2022 1.77 Mn
Dec 31, 2021 7.35 Mn
Dec 31, 2021 7.35 Mn